NCT02723097

Brief Summary

The objective of this protocol is to test the feasibility and acceptability of the Relaxation Response Resiliency Program (3RP), a psychotherapy treatment providing a variety of mind body skills and interventions to decrease medical and mental health symptoms and build resilience, in Spanish-speaking World Trade Center (WTC) survivors, and to examine its clinical effectiveness to reduce Post Traumatic Stress Disorder (PTSD), depression, anxiety, and lower respiratory symptoms (LRS) and improve psychosocial functioning.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
20

participants targeted

Target at below P25 for not_applicable

Timeline
Completed

Started Mar 2016

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

March 1, 2016

Completed
23 days until next milestone

First Submitted

Initial submission to the registry

March 24, 2016

Completed
6 days until next milestone

First Posted

Study publicly available on registry

March 30, 2016

Completed
1.5 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

October 11, 2017

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

October 11, 2017

Completed
Last Updated

October 18, 2017

Status Verified

October 1, 2017

Enrollment Period

1.6 years

First QC Date

March 24, 2016

Last Update Submit

October 16, 2017

Conditions

Outcome Measures

Primary Outcomes (7)

  • Structured Clinical Interview (SCID-NP) for Diagnostic and Statistical Manual DSM-IV

    State-of-the-art instrument for obtaining psychiatric diagnoses.

    1 Month

  • Symptom Severity using PTSD Checklist

    Symptoms will be assessed with the PTSD Checklist (PCL), a 17-item self-report measure of current (past month) PTSD symptoms based on the DSM-IV criteria. It is a widely-used and validated measure of PTSD symptom severity.

    1 Month

  • Assessment of Anxiety Symptoms using Generalized Anxiety Disorder Scale (GAD-7)

    1 Month

  • Measure of Functional Impairment using the Range of Impaired Functioning Tool (RIFT)

    widely-used instrument that taps the domains of work, household duties, interpersonal relationships, recreation, and subjective satisfaction with life. Each domain is rated on a five-point scale from very good to very poor. The total score is the sum of the different domains.

    1 Month

  • Assessment of Mindful attention using Mindful Attention Awareness Scale (MAAS)

    The MAAS is a 15-item questionnaire on which respondents indicate, on a 6 point Likert-type scale (1 = almost always to 6 = almost never), their level of awareness and attention to present events and experiences.

    1 Month

  • Health Promoting Behaviors will be assessed with the Health Promoting Lifestyles Profile-II (HPLP-II)

    he HPLP-II is a 52 item self-report inventory of health behaviors and has been used in previous mind-body treatment studies

    1 Month

  • Measure of treatment expectancy using the Treatment Credibility/Expectancy Questionnaire.

    The 6-item Treatment Credibility/Expectancy Questionnaire (CEQ)84 will be used to examine treatment expectancy related to the 3RP.

    1 Month

Study Arms (1)

Relaxation Response Resiliency Program (3RP)

EXPERIMENTAL
Behavioral: 3 RP

Interventions

3 RPBEHAVIORAL
Also known as: Relaxation Response Resiliency Program
Relaxation Response Resiliency Program (3RP)

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • score \> or = 44 on the PTSD Checklist PCL, considered the broad definition of PTSD syndrome71
  • report at least one LRS symptoms (i.e., shortness of breath, wheezing, dyspnea or cough).
  • Spanish Speaking

You may not qualify if:

  • regular practice of eliciting relaxation response (i.e., meditation, yoga) in the past 6 months,
  • serious unmanaged mental illness including bipolar disorder, psychosis, and active substance misuse disorders;
  • inability to participate in consecutive sessions over 3-month period.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

New York University School of Medicine

New York, New York, 10016, United States

Location

MeSH Terms

Conditions

Stress Disorders, Post-Traumatic

Condition Hierarchy (Ancestors)

Stress Disorders, TraumaticTrauma and Stressor Related DisordersMental Disorders

Study Officials

  • Lucia Ferri, MD

    New York University Medical School

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
interventional
Phase
not applicable
Allocation
NA
Masking
NONE
Purpose
SUPPORTIVE CARE
Intervention Model
SINGLE GROUP
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

March 24, 2016

First Posted

March 30, 2016

Study Start

March 1, 2016

Primary Completion

October 11, 2017

Study Completion

October 11, 2017

Last Updated

October 18, 2017

Record last verified: 2017-10

Locations